THERAPEUTIC EFFECTS OF ZINC SULPHATE IN REDUCTION OF NEONATAL HYPERBILIRUBINEMIA: AN EXPERIMENTAL STUDY
Abstract
Objective: Neonatal hyperbilirubinemia is a common condition affecting 60% of the term and 80% of the preterm neonates. Bilirubin can be neurotoxic, when its concentration rises more than 20mg/dl which occurs in 2% of infants. The most prevalent therapeutic method for managing infantile icterus and preventing its complications is phototherapy and exchange transfusions at higher bilirubin levels.
Material and Methods: A quasi experimental study was conducted on 60 neonates with hyperbilirubinemia. They were randomly divided into two groups. Group A (n=30) received zinc sulphate 5mg twice daily for 5 days, in addition to phototherapy. Group B (n=30) received phototherapy. Total serum bilirubin was calculated at 0, 24 and 72 hours for both groups.
Results: No significant difference was found in total serum bilirubin at 0, 24 and 72 hours in both groups (p=0.46, 0.39 and 0.20 respectively)
Conclusion: Oral zinc sulphate is not effective in the treatment of hyperbilirubinemia in neonates.
Key Words: Jaundice, Hyperbilirubinemia, Zinc sulphate, Phototherapy, Physiological Jaundice, Neonate
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Ayesha Waheed, Iqtada Haider Shirazi, Asma Mustafa, Yasir Waheed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.